SNGX 주가 차트
SNGX 주가 예측
Soligenix Inc
$0.42
-70.25%
$-0.99
종가: Apr 28, 16:00:00 GMT-4
$0.4
-2.75%
$-0.01
프리마켓: Apr 29, 06:54:35 GMT-4
뒤로
Soligenix Inc (SNGX) 주가 예측
주요 통계
이전 종가
$1.41
시가
$0.6106
일일 범위
$0.3701 - $0.6337
52주 범위
$0.4093 - $6.23
거래량
14.9M
평균 거래량
224.2K
배당수익률
--
EPS(TTM)
-2.76
시가총액
$4.2M
SNGX란 무엇인가요?
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).
